Pituitary disease in pediatric brain tumor survivors

References

• Merchant TE, Williams T, Smith JM, et al. Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function. Int J Radiat Oncol Biol Phys. 2002;54(1):45–50.
   PubMed Web of Science ®Google Scholar
• Rose SR, Schreiber RE, Kearney NS, et al. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab. 2004;17(1):55–66.
   PubMed Web of Science ®Google Scholar
• Román J, Villaizán CJ, García-Foncillas J, et al. Growth and growth hormone secretion in children with cancer treated with chemotherapy. J Pediatr. 1997;131(1):105–112.
   PubMed Web of Science ®Google Scholar
• Agha A, Sherlock M, Brennan S, et al. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab. 2005;90(12):6355–6360.
   PubMed Web of Science ®Google Scholar
• Borson-Chazot F, Brue T. Pituitary deficiency after brain radiation therapy. Ann Endocrinol. 2006;67(4):303–309.
   PubMed Web of Science ®Google Scholar
• Darzy KH, Shalet SM. Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary. 2005;8(3–4):203–211.
   PubMedGoogle Scholar
• Kalapurakal JA. Radiation therapy in the management of pediatric craniopharyngiomas—a review. Child’s Nerv Syst. 2005;21(8–9):808–816.
   PubMed Web of Science ®Google Scholar
• Pai HH, Thornton A, Katznelson L, et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose–effect relationship using dose–volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001;49(4):1079–1092.
   PubMed Web of Science ®Google Scholar
• Rose SR, Horne VE, Howell J, et al. Late endocrine effects of childhood cancer. Nat Rev Endocrinol. 2016 Jun;12(6):319–336.
   PubMed Web of Science ®Google Scholar
• Sklar CA, Antal Z, Chemaitilly W, et al. Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2761–2784.
   PubMed Web of Science ®Google Scholar
• Chemaitilly W, Cohen LE. Diagnosis of endocrine disease: endocrine late-effects of childhood cancer and its treatments. Eur J Endocrinol. 2017 Apr;176(4):R183–R203.
   PubMed Web of Science ®Google Scholar
• Cohen JE, Wakefield CE, Cohn RJ. Nutritional interventions for survivors of childhood cancer. Cochrane Database Syst Rev. 2016 Aug 22;(8). CD009678. DOI:10.1002/14651858.
   Web of Science ®Google Scholar
• Voelker JL, Campbell RL, Muller J. Clinical, radiographic, and pathological features of symptomatic Rathke’s cleft cysts. J Neurosurg. 1991;535–544.
   PubMed Web of Science ®Google Scholar
• Cerman J, Cap J, Marekova M, et al. The role of apoptosis in pituitary adenomas in the field of conventionally used therapeutic approaches. Ann N Y Acad Sci. 2003;1010(1):520–524.
   PubMed Web of Science ®Google Scholar
• Jereczek-Fossa BA, Alterio D, Jassem J, et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev. 2004;30(4):369–384.
   PubMed Web of Science ®Google Scholar
• Marquette C, Linard C, Galonnier M, et al. IL-1 β, TNF α and IL-6 induction in the rat brain after partial body irradiation: role of vagal afferents. Int J Radiat Biol. 2003;79(10):777–785.
   PubMed Web of Science ®Google Scholar
• Woiciechowsky C, Schöning B, Cobanov J, et al. Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma Acute Care Surg. 2002;52(2):339–345.
   Web of Science ®Google Scholar
• Levegrün S, Hof H, Essig M, et al. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters. Int J Radiat Oncol Biol Phys. 2004;59(3):796–808.
   PubMed Web of Science ®Google Scholar
• Steen RG, Spence D, Wu S, et al. Effect of therapeutic ionizing radiation on the human brain. Ann Neurol. 2001;50(6):787–795.
   PubMed Web of Science ®Google Scholar
• Guo Y-P, Hendry JH, Morris ID, et al. Cell proliferation and death in the irradiated pituitary gland and its modification by growth stimulants. Int J Radiat Oncol Biol Phys. 1997;38(1):175–181.
   PubMed Web of Science ®Google Scholar
• Mareková M, Cáp J, Vokurková D, et al. Effect of therapeutic doses of ionising radiation on the somatomammotroph pituitary cell line, GH3. Endocr J. 2003;50(5):621–628.
   PubMed Web of Science ®Google Scholar
• Darzy KH, Aimaretti G, Wieringa G, et al. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab. 2003;88(1):95–102.
   PubMed Web of Science ®Google Scholar
• Gleeson HK, Gattamaneni HR, Smethurst L, et al. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy. J Clin Endocrinol Metab. 2004;89(2):662–666.
   PubMed Web of Science ®Google Scholar
• Littley MD, Shalet SM, Beardwell CG, et al. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf). 1989;31(3):363–373.
   PubMed Web of Science ®Google Scholar
• Woodruff KH, Lyman JT, Lawrence JH, et al. Delayed sequelae of pituitary irradiaton. Hum Pathol. 1984;15(1):48–54.
   PubMed Web of Science ®Google Scholar
• Adan L, Trivin C, Sainte-Rose C, et al. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab. 2001;86(11):5245–5251.
   PubMed Web of Science ®Google Scholar
• Merchant TE, Rose SR, Bosley C, et al. Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol. 2011;29(36):4776–4780.
   PubMed Web of Science ®Google Scholar
• Grabenbauer GG, Schuchardt U, Buchfelder M, et al. Radiation therapy of optico–hypothalamic gliomas (OHG) – radiographic response, vision and late toxicity. Radiother Oncol. 2000;54(3):239–245.
   PubMed Web of Science ®Google Scholar
• Robinson IC, Fairhall KM, Hendry JH, et al. Differential radiosensitivity of hypothalamo-pituitary function in the young adult rat. J Endocrinol. 2001;169(3):519–526.
   PubMed Web of Science ®Google Scholar
• Haller MJ, Schatz DA. Endocrine complications of childhood cancer therapy: evaluation and management. Pediatr Endocrinol Rev. 2007;4(3):196–204.
   PubMedGoogle Scholar
• Lewandowski K, Dąbrowska K, Makarewicz J, et al. Pendulum swings from hypo- to hyperthyroidism: thyrotoxicosis after severe hypothyroidism following neck irradiation in a patient with a history of Hodgkin’s lymphoma. Thyroid Res. 2016 Jan 15;9:1.
   PubMed Web of Science ®Google Scholar
• Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;25(7):716–759.
   PubMed Web of Science ®Google Scholar
• Taylor AJ, Croft AP, Palace AM, et al. Risk of thyroid cancer in survivors of childhood cancer: results from the british childhood cancer survivor study. Int J Cancer. 2009;125(10):2400–2405.
   PubMed Web of Science ®Google Scholar
• McMullen T, Bodie G, Gill A, et al. Hyperparathyroidism after irradiation for childhood malignancy. Int J Radiat Oncol Biol Phys. 2009;73(4):1164–1168.
   PubMed Web of Science ®Google Scholar
• Hoeben BA, Carrie C, Timmermann B, et al. Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group. Lancet Oncol. 2019 Mar;20(3):e155–e166.
   PubMed Web of Science ®Google Scholar
• Xu W, Janss A, Moshang T. Adult height and adult sitting height in childhood medulloblastoma survivors. J Clin Endocrinol Metab. 2003;88(10):4677–4681.
   PubMed Web of Science ®Google Scholar
• Beltran C, Roca M, Merchant TE. On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys. 2012;82(2):e281–7.
   PubMedGoogle Scholar
• Mailhot Vega R, Kim J, Hollander A, et al. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer. 2015;121(10):1694–1702.
   PubMed Web of Science ®Google Scholar
• Viswanathan V, Pradhan KR, Eugster EA. Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors. Endocr Pract. 2011;17(6):891–896.
   PubMed Web of Science ®Google Scholar
• Bielamowicz K, Okcu MF, Sonabend R, et al. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatr Hematol Oncol. 2018;35(4):257-267.
   Web of Science ®Google Scholar
• Eaton BR, Esiashvili N, Kim S, et al. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2016 Jun;18(6):881–887.
   PubMed Web of Science ®Google Scholar
• Greenberger BA, Pulsifer MB, Ebb DH, et al. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014;89(5):1060–1068.
   PubMed Web of Science ®Google Scholar
• Baliga S, Yock TI. Proton beam therapy in pediatric oncology. Curr Opin Pediatr. 2019 Feb;31(1):28–34.
   PubMed Web of Science ®Google Scholar
• Huynh M, Marcu LG, Giles E, et al. Are further studies needed to justify the use of proton therapy for paediatric cancers of the central nervous system? A review of current evidence. Radiother Oncol. 2019 Apr;133:140–148.
   PubMed Web of Science ®Google Scholar
• Klose M, Jonsson B, Abs R, et al. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis. Eur J Endocrinol. 2009;161(Suppl 1):S75–83.
   PubMed Web of Science ®Google Scholar
• Lam KS, Tse VK, Wang C, et al. Effects of cranial irradiation on hypothalamic-pituitary function–a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q J Med. 1991;78(286):165–176.
   PubMedGoogle Scholar
• Mulder RL, Kremer LC, van Santen HM, et al. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review. Cancer Treat Rev. 2009;35(7):616–632.
   PubMed Web of Science ®Google Scholar
• Lawson S, Horne VE, Golekoh MC, et al. Hypothalamic-pituitary function following childhood brain tumors: analysis of prospective annual endocrine screening. Pediatr Blood Cancer. 66(5):e27631. Epub 2019 Jan 28.
   PubMed Web of Science ®Google Scholar
• Kubota M, Yagi M, Kanada S, et al. Long-term follow-up status of patients with neuroblastoma after undergoing either aggressive surgery or chemotherapy–a single institutional study. J Pediatr Surg. 2004;39(9):1328–1332.
   PubMed Web of Science ®Google Scholar
• van Dorp W, van Beek RD, Laven JS, et al. Long-term endocrine side effects of childhood Hodgkin’s lymphoma treatment: a review. Hum Reprod Update. 2012;18(1):12–28.
   PubMed Web of Science ®Google Scholar
• Gilchrist FJ, Murray RD, Shalet SM. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clin Endocrinol (Oxf). 2002;57(3):363–370.
   PubMed Web of Science ®Google Scholar
• Leung W, Hudson MM, Strickland DK, et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol. 2000;18(18):3273–3279.
   PubMed Web of Science ®Google Scholar
• Leung W, Rose SR, Zhou Y, et al. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2002;20(13):2959–2964.
   PubMed Web of Science ®Google Scholar
• Sklar CA. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am. 1997;44(2):489–503.
   PubMed Web of Science ®Google Scholar
• Shalet SM. Radiation and pituitary dysfunction. N Engl J Med. 1993;328(2):131–133.
   PubMed Web of Science ®Google Scholar
• Schmiegelow M, Lassen S, Poulsen HS, et al. Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors. Horm Res. 2000;54(2):53–59.
   PubMedGoogle Scholar
• Darzy KH, Pezzoli SS, Thorner MO, et al. The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness. J Clin Endocrinol Metab. 2005;90(5):2794–2803.
   PubMed Web of Science ®Google Scholar
• Chung TT, Drake WM, Evanson J, et al. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement. Clin Endocrinol (Oxf). 2005;63(3):274–279.
   PubMed Web of Science ®Google Scholar
• Rose SR. Improved diagnosis of mild hypothyroidism using time-of-day normal ranges for thyrotropin. J Pediatr. 2010;157(4):662–7;667 e661.
   Web of Science ®Google Scholar
• Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3–126.
   PubMed Web of Science ®Google Scholar
• Rose SR. Isolated central hypothyroidism in short stature. Pediatr Res. 1995;38(6):967–973.
   PubMed Web of Science ®Google Scholar
• Rose SR, Lustig RH, Pitukcheewanont P, et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab. 1999;84(12):4472–4479.
   PubMed Web of Science ®Google Scholar
• Rose SR, Lawson SA, Burns K, et al. Endocrine complications of cancer therapy. In: Schwartz C, Hobbie W, Constine L, et al., editors. Survivors of childhood and adolescent cancer: a multidisciplinary approach. Berlin: Springer-Verlag GmBH & Co; 2015. p. 65–94.
   Google Scholar
• Kyriakakis N, Lynch J, Orme SM, et al. Hypothalamo-pituitary axis irradiation dose thresholds for development of hypopituitarism in adult-onset gliomas. Clin Endocrinol (Oxf). 2019 Mar 15; Epub ahead of print. DOI:10.1111/cen.13971.
   PubMed Web of Science ®Google Scholar
• Yanovski JA, Rose SR, Municchi G, et al. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med. 2003;348(10):908–917.
   PubMed Web of Science ®Google Scholar
• Berberoglu M. Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management. J Clin Res Pediatr Endocrinol. 2009;1(4):164–174.
   PubMedGoogle Scholar
• Herman-Giddens ME. Recent data on pubertal milestones in United States children: the secular trend toward earlier development. Int J Androl. 2006;29(1):241–246. discussion 286-90.
   PubMedGoogle Scholar
• Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics. 1997;99(4):505–512.
   PubMed Web of Science ®Google Scholar
• Oberfield SE, Soranno D, Nirenberg A, et al. Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Adolesc Med. 1996;150(6):589–592.
   PubMedGoogle Scholar
• Chemaitilly W, Merchant TE, Li Z, et al. Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes. Clin Endocrinol (Oxf). 2016;84(3):361–371.
   PubMed Web of Science ®Google Scholar
• Walvoord EC. The timing of puberty: is it changing? Does it matter? J Adolesc Health. 2010;47(5):433–439.
   PubMed Web of Science ®Google Scholar
• Leader A, Lishner M, Michaeli J, et al. Fertility considerations and preservation in haemato-oncology patients undergoing treatment. Br J Haematol. 2011;153(3):291–308.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Whitton JA, Gajjar A, et al. Abnormal timing of menarche in survivors of central nervous system tumors: a report from the childhood cancer survivor study. Cancer. 2009;115(11):2562–2570.
   PubMed Web of Science ®Google Scholar
• Devin JK. Hypopituitarism and central diabetes insipidus: perioperative diagnosis and management. Neurosurg Clin N Am. 2012;23(4):679–689.
   PubMed Web of Science ®Google Scholar
• Shohdy KS, Rashad W. Endocrine disorders developing after surgical intervention of craniopharyngioma in children. Pediatr Endocrinol Rev. 2017;14(3):298–301.
   PubMed Web of Science ®Google Scholar
• Wijetilleka S, Khan M, Mon A, et al. Cranial diabetes insipidus with pituitary stalk lesions. Qjm. 2016;109(11):703–708.
   PubMed Web of Science ®Google Scholar
• Di Iorgi N, Morana G, Napoli F, et al. Management of diabetes insipidus and adipsia in the child. Best Pract Res Clin Endocrinol Metab. 2015;29(3):415–436.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Gebhardt U, Sterkenburg AS, et al. Diencephalic syndrome in childhood craniopharyngioma–results of German multicenter studies on 485 long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab. 2014 Nov;99(11):3972–3977.
   PubMed Web of Science ®Google Scholar
• Lustig RH. Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne). 2011;2:60.
   PubMedGoogle Scholar
• Kim JH, Choi JH. Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents. Ann Pediatr Endocrinol Metab. 2013;18(4):161–167.
   PubMedGoogle Scholar
• Lustig RH, Post SR, Srivannaboon K, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003;88(2):611–616.
   PubMed Web of Science ®Google Scholar
• Elowe-Gruau E, Beltrand J, Brauner R, et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab. 2013;98(6):2376–2382.
   PubMed Web of Science ®Google Scholar
• Haliloglu B, Bereket A. Hypothalamic obesity in children: pathophysiology to clinical management. J Pediatr Endocrinol Metab. 2015;28(5–6):503–513.
   PubMed Web of Science ®Google Scholar
• Inoue S, Nagase H, Satoh S, et al. Role of the efferent and afferent vagus nerve in the development of ventromedial hypothalamic (VMH) obesity. Brain Res Bull. 1991;27(3–4):511–515.
   PubMed Web of Science ®Google Scholar
• Bm K, LA F. The role of vagally-medicated hyperinsulinemia in hypothalamic obesity. Neurosci Biobehav Rev. 1982;6(2):205–214.
   PubMed Web of Science ®Google Scholar
• De Silva A, Bloom SR. Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver. 2012;6(1):10–20.
   PubMed Web of Science ®Google Scholar
• O’Gorman CS, Simoneau-Roy J, Mb P P, et al. Delayed ghrelin suppression following oral glucose tolerance test in children and adolescents with hypothalamic injury secondary to craniopharyngioma compared with obese controls. Int J Pediatr Obes. 2011;6(3–4):285–288.
   PubMed Web of Science ®Google Scholar
• Gebauer J, Higham C, Langer T, et al. Long-term endocrine and netabolic consequences of cancer treatment: a systematic review. Endocr Rev. 2018 Nov 23. Epub ahead of print. DOI:10.1210/er.2018-00092.
   Web of Science ®Google Scholar
• Chemaitilly W, Sklar CA. Childhood cancer treatments and associated endocrine late effects: a concise guide for the pediatric endocrinologist. Horm Res Paediatr. 2018 Nov;7:1–9.
   Web of Science ®Google Scholar
• Degerblad M, Brismar K, Rahn T, et al. The hypothalamus-pituitary function after pituitary stereotactic radiosurgery: evaluation of growth hormone deficiency. J Intern Med. 2003;253(4):454–462.
   PubMed Web of Science ®Google Scholar
• Feigl GC, Bonelli CM, Berghold A, et al. Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg. 2002;97:415–421.
   PubMed Web of Science ®Google Scholar
• Vladyka V, Liščák R, Novotný J, et al. Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery. 2003;52(2):309–317.
   PubMed Web of Science ®Google Scholar
• Fuss M, Hug EB, Schaefer RA, et al. Proton radiation therapy (prt) for pediatric optic pathway gliomas: comparison with 3d planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys. 1999;45(5):1117–1126.
   PubMed Web of Science ®Google Scholar
• Winterer J, Barnes KM, Lichter AS, et al. Effect of gonadotropin secretion rate on the radiosensitivity of the rat luteinizing hormone-releasing hormone neuron and gonadotroph. Endocrinology. 1988;122(3):884–890.
   PubMed Web of Science ®Google Scholar
• Schunior A, Mullenix PJ, Zengel AE, et al. Radiation effects on growth are altered in rats by prednisolone and methotrexate. Pediatr Res. 1994;35(4):416–423.
   PubMed Web of Science ®Google Scholar
• Gilad GM, Gilad VH. Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cell Mol Neurobiol. 2003;23(4–5):637–649.
   PubMed Web of Science ®Google Scholar
• Zanni G, Di Martino E, Omelyanenko A, et al. Lithium increases proliferation of hippocampal neural stem/progenitor cells and rescues irradiation-induced cell cycle arrest in vitro. Oncotarget. 2015 Nov 10;6(35):37083–37097.
   PubMedGoogle Scholar
• Huang T-S, Huang S-C, Hsu -M-M. A prospective study of hypothalamus pituitary function after cranial irradiation with or without radiosensitizing chemotherapy. J Endocrinol Invest. 1994;17(8):615–663.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Liu Q, Yasui Y, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the childhood cancer survivor study. Jnci. 2009;101(13):946–958.
   PubMed Web of Science ®Google Scholar
• Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: childhood cancer survivor study. Cancer. 2003;97(3):663–673.
   PubMed Web of Science ®Google Scholar
• Hudson MM, Mulrooney DA, Bowers DC, et al. High-risk populations identified in childhood cancer survivor study investigations: implications for risk-based surveillance. J Clin Oncol. 2009;27(14):2405–2414.
   PubMed Web of Science ®Google Scholar
• Pereira N, Schattman GL. Fertility preservation and sexual health after cancer therapy. J Oncol Pract. 2017;13(10):643–651.
   PubMed Web of Science ®Google Scholar
• Trudgen K, Ayensu-Coker L. Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient. Curr Opin Obstet Gynecol. 2014;26(5):372–380.
   PubMed Web of Science ®Google Scholar
• Bowers DC, Adhikari S, El-Khashab YM, et al. Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors. Pediatr Blood Cancer. 2009;53(7):1295–1301.
   PubMed Web of Science ®Google Scholar
• Essig S, Skinner R, von der Weid NX, et al. Follow-up programs for childhood cancer survivors in Europe: a questionnaire survey. PLoS ONE. 2012;7(12):e53201.
   PubMed Web of Science ®Google Scholar
• Gage EA, Pailler M, Zevon MA, et al. Structuring survivorship care: discipline-specific clinician perspectives. J Cancer Survivorship. 2011;5(3):217–225.
   PubMed Web of Science ®Google Scholar
• Judge Santacroce S, Asmus K, Kadan-Lottick N, et al. Feasibility and preliminary outcomes from a pilot study of coping skills training for adolescent—young adult survivors of childhood cancer and their parents. J Pediatr Oncol Nurs. 2010;27(1):10–20.
   PubMed Web of Science ®Google Scholar
• Shad A, Myers SN, Hennessy K. Late effects in cancer survivors: “The shared care model”. Curr Oncol Rep. 2012;14(2):182–190.
   PubMed Web of Science ®Google Scholar
• Haddy TB, Mosher RB, Reaman GH. Late effects in long-term survivors after treatment for childhood acute leukemia. Clin Pediatr (Phila). 2009;48(6):601–608.
   PubMed Web of Science ®Google Scholar
• Nathan PC, Greenberg ML, Ness KK, et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26(27):4401–4409.
   PubMed Web of Science ®Google Scholar
• Hjorth L, Haupt R, Skinner R, et al. Survivorship after childhood cancer: panCare: a European network to promote optimal long-term care. Eur J Cancer. 2015;5110:1203–1211. Available from https://www.pancare.eu/en/.
   PubMed Web of Science ®Google Scholar
• Lee Y-L, Gau B-S, Hsu W-M, et al. A model linking uncertainty, post-traumatic stress, and health behaviors in childhood cancer survivors. Oncol Nurs Forum. 2009;36(1):E20–30.
   PubMed Web of Science ®Google Scholar
• Eakin EG, Youlden DR, Baade PD, et al. Health behaviors of cancer survivors: data from an Australian population-based survey. Cancer Causes Control. 2007;18(8):881–894.
   PubMed Web of Science ®Google Scholar
• James EL, Stacey FG, Chapman K, et al. Impact of a nutrition and physical activity intervention (ENRICH: Exercise and nutrition routine improving cancer health) on health behaviors of cancer survivors and carers: a pragmatic randomized controlled trial. BMC Cancer. 2015;15(1):710.
   PubMed Web of Science ®Google Scholar
• Stacey FG, James EL, Chapman K, et al. A systematic review and meta-analysis of social cognitive theory-based physical activity and/or nutrition behavior change interventions for cancer survivors. J Cancer Survivorship. 2015;9(2):305–338.
   PubMed Web of Science ®Google Scholar
• Zhang FF, Parsons SK. Obesity in childhood cancer survivors: call for early weight management. Adv Nutr. 2015;6(5):611–619.
   PubMed Web of Science ®Google Scholar
• Sabatino SA, Coates RJ, Uhler RJ, et al. Provider counseling about health behaviors among cancer survivors in the United States. J Clin Oncol. 2007;25(15):2100–2106.
   PubMed Web of Science ®Google Scholar
• Temkin SM, Seibel NL. Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers: hpv vaccines and childhood cancer survivors. Cancer. 2015;121(19):3395–3402.
   PubMed Web of Science ®Google Scholar
• Brouwer CAJ, Gietema JA, Vonk JM, et al. Body mass index and annual increase of body mass index in long-term childhood cancer survivors; relationship to treatment. Support Care Cancer. 2012;20(2):311–318.
   PubMed Web of Science ®Google Scholar
• Elchuri SV, Patterson BC, Wasilewski-Masker K, et al. Perceptions of body mass index (BMI) in pediatric cancer survivors and their providers: perceptions of BMI for cancer survivors. Pediatr Blood Cancer. 2014;61(8):1445–1450.
   PubMed Web of Science ®Google Scholar
• Ross JA. Genetic susceptibility and body mass in childhood cancer survivors. Pediatr Blood Cancer. 2007;48(7):731–735.
   PubMed Web of Science ®Google Scholar
• Siviero-Miachon AA, CMdC M, Pires LV, et al. Early traits of metabolic syndrome in pediatric post-cancer survivors: outcomes in adolescents and young adults treated for childhood medulloblastoma. Arquivos Brasileiros De Endocrinologia & Metabologia. 2011;55(8):653–660.
   PubMedGoogle Scholar
• Bellizzi KM, Rowland JH, Jeffery DD, et al. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23(34):8884–8893.
   PubMed Web of Science ®Google Scholar
• Blanchard CM, Courneya KS, Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198–2204.
   PubMed Web of Science ®Google Scholar
• Nathan PC, Ford JS, Henderson TO, et al. Health behaviors, medical care, and interventions to pomote healthy living in the childhood cancer survivor study cohort. J Clin Oncol. 2009;27(14):2363–2373.
   PubMed Web of Science ®Google Scholar